3A Research, LLC

1. Taro Pharmaceuticals USA, Inc. $1,463,800 113 payments
2. Moderna TX, Inc. $1,019,613 15 payments

1. A Phase 3, Randomized, Observer-blind, Active-controlled, Case-drivenStudy to Investigate the Safety, Efficacy, and Immunogenicity of mRNA-1010 Candidate Seasonal Influenza Vaccine Compared with a Licensed Inactivated Seasonal Influenza Vaccine in Adults 50 Years of Age $612,955 4 payments
2. A Phase 3, randomized, observerblind, activecontrol study to evaluate the safety, reactogenicity, and immunogenicity of mRNA1083 (SARSCoV2 and influenza) vaccine in healthy adult participants, 50 years of age. $406,658 11 payments
3. A Multi-center, Double-Blind, Randomized, Placebo Controlled, Parallel-Group Study, Comparing Tretinoin Cream 0.025% (Taro Pharmaceuticals U.S.A) and RETIN-A (Tretinoin) Cream 0.025% and Both Active Treatment to a Placebo Control in the Treatment of Acne Vulgaris $252,999 12 payments
4. A Multi-center, Double-Blind, Randomized, Placebo Controlled, Parallel-Group Study, Comparing Adapalene Gel 0.1% (XXXXXX) to Differin Gel (Adapalene 0.1%, Galderma) and Both Active Treatments to a Placebo Control in the Treatment of Acne Vulgaris $220,824 13 payments
5. Ivrc 2002 $203,670 21 payments
6. BTCG 1808 $171,305 24 payments
7. Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgaris $157,203 8 payments
8. TRTN 1619 $148,635 7 payments
9. To Evaluate the Therapeutic Equivalence and Safety of Azelaic Acid 15 Topical Gel $107,781 11 payments
10. Ta103-2004 $67,095 3 payments

1. Professional salary support $1,422,550 104 payments
2. Overhead $41,250 9 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.